Mary Stoll

Mary Stoll is an experienced clinical development professional currently serving as the Clinical Development Lead for the RESONIC study at AbbVie since April 2022. Prior to this role, Mary held several leadership positions at Soliton, Inc., including Vice President of Clinical Affairs and Senior Director of Clinical Development from December 2019 to April 2022. Additional experience includes serving as Senior Director of Clinical Operations at Cytrellis Biosystems, Inc. from December 2018 to December 2019 and Executive Director of Clinical Education at Cynosure, Inc. from September 2013 to October 2018. Mary Stoll holds a Bachelor of Science degree in Nursing, Health and Science Studies, and Psychology from Quinnipiac University and graduated from Sacred Heart High School.